LINDEN ADVISORS LP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$36,154,222
+13.2%
42,025,000
+13.5%
0.37%
+10.7%
Q2 2023$31,949,534
+143.0%
37,025,000
+143.9%
0.34%
+142.8%
Q1 2023$13,147,664
-77.5%
15,182,000
-76.1%
0.14%
-61.5%
Q4 2021$58,560,00063,485,0000.36%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 135,834,000$118,179,3033.86%
STEELHEAD PARTNERS LLC 50,000,000$43,056,2502.73%
DeepCurrents Investment Group LLC 45,000,000$38,654,8931.53%
Opti Capital Management, LP 18,000,000$15,570,0001.32%
WOLVERINE ASSET MANAGEMENT LLC 58,557,000$50,549,2740.60%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,856,000$4,168,6020.59%
SHENKMAN CAPITAL MANAGEMENT INC 7,180,000$6,246,7940.49%
Context Capital Management, LLC 4,489$3,9060.35%
LINDEN ADVISORS LP 37,025,000$31,949,5340.34%
TENOR CAPITAL MANAGEMENT Co., L.P. 14,000,000$12,091,1100.25%
View complete list of NOVOCURE LTD shareholders